• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4642359)   Today's Articles (79)   Subscriber (50473)
For: Yoshida Y, Yamada J, Watanabe T, Suga T, Takayama H. Participation of the peroxisomal beta-oxidation system in the chain-shortening of PCA16, a metabolite of the cytosine arabinoside prodrug, YNKO1, in rat liver. Biochem Pharmacol 1990;39:1505-12. [PMID: 2337407 DOI: 10.1016/0006-2952(90)90514-l] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Number Cited by Other Article(s)
1
Zhang Y, Fan C, Zhang J, Tian X, Zuo W, He K. Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: A versatile drug delivery paradigm. Eur J Med Chem 2024;275:116614. [PMID: 38925014 DOI: 10.1016/j.ejmech.2024.116614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Revised: 06/16/2024] [Accepted: 06/20/2024] [Indexed: 06/28/2024]
2
Zwueste DM, Vernau KM, Vernau W, Pypendop BH, Knych HK, Rodrigues CA, Kol A, Questa M, Dickinson PJ. Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs. J Vet Intern Med 2023;37:2429-2442. [PMID: 37670479 PMCID: PMC10658504 DOI: 10.1111/jvim.16842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Accepted: 08/21/2023] [Indexed: 09/07/2023]  Open
3
Lipka E, Chadderdon AM, Harteg CC, Doherty MK, Simon ES, Domagala JM, Reyna DM, Hutchings KM, Gan X, White AD, Hartline CB, Harden EA, Keith KA, Prichard MN, James SH, Cardin RD, Bernstein DI, Spencer JF, Tollefson AE, Wold WSM, Toth K. NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin. Mol Pharm 2023;20:370-382. [PMID: 36484496 PMCID: PMC9811456 DOI: 10.1021/acs.molpharmaceut.2c00668] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Revised: 11/03/2022] [Accepted: 11/16/2022] [Indexed: 12/13/2022]
4
Schwede F, Rentsch A, Genieser HG. Medicinal Chemistry of the Noncanonical Cyclic Nucleotides cCMP and cUMP. Handb Exp Pharmacol 2017;238:307-337. [PMID: 27896476 DOI: 10.1007/164_2015_41] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
5
Lismont C, Nordgren M, Van Veldhoven PP, Fransen M. Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol 2015;3:35. [PMID: 26075204 PMCID: PMC4444963 DOI: 10.3389/fcell.2015.00035] [Citation(s) in RCA: 132] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2015] [Accepted: 05/09/2015] [Indexed: 12/14/2022]  Open
6
Chhikara BS, Parang K. Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opin Drug Deliv 2010;7:1399-414. [PMID: 20964588 DOI: 10.1517/17425247.2010.527330] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
7
Yamaguchi Y, Touchi A, Baba T, Matsubara T. Species differences in β-oxidative metabolism of a thromboxane A2-receptor antagonist [(+)-S-145] in rat, dog and monkey. Xenobiotica 2010. [DOI: 10.1080/0049825011004350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
8
Hecker SJ, Erion MD. Prodrugs of Phosphates and Phosphonates. J Med Chem 2008;51:2328-45. [DOI: 10.1021/jm701260b] [Citation(s) in RCA: 295] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
9
Rosti G, Bonifazi F, Trabacchi E, De Vivo A, Bassi S, Martinelli G, Testoni N, Russo D, Baccarani M. A phase II study of alpha-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia. Leukemia 2003;17:554-9. [PMID: 12646944 DOI: 10.1038/sj.leu.2402850] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
10
Suga T. Drug Metabolism in Peroxisomes: Involvement of Peroxisomal β-Oxidation System in the Oxidative Chain-shortening of Xenobiotic Acyl Compounds. Drug Metab Pharmacokinet 2003;18:155-62. [PMID: 15618731 DOI: 10.2133/dmpk.18.155] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
11
Kühr T, Eisterer W, Apfelbeck U, Linkesch W, Bechter O, Zabernigg A, Geissler K, Barbieri G, Duba C, Gastl G, Thaler J. Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study. Leuk Res 2000;24:583-7. [PMID: 10867132 DOI: 10.1016/s0145-2126(00)00036-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
12
Wanders RJ, Tager JM. Lipid metabolism in peroxisomes in relation to human disease. Mol Aspects Med 1998;19:69-154. [PMID: 9827430 DOI: 10.1016/s0098-2997(98)00003-x] [Citation(s) in RCA: 98] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
13
Yamaguchi Y, Norikura R, Nakanishi M, Touchi A, Yoshimori T, Murakami T, Baba T, Mizojiri K, Matsubara T. Sex differences in the metabolism of (+)-S-145, a novel thromboxane A2 receptor antagonist in rat. Xenobiotica 1996;26:613-26. [PMID: 8810032 DOI: 10.3109/00498259609046737] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
14
Ramsauer B, Braess J, Unterhalt M, Kaufmann CC, Hiddemann W, Schleyer E. Highly sensitive high-performance liquid chromatographic assay for 1-beta-D-arabinofuranosylcytosine-5'-stearyl phosphate (cytarabine-ocfosfate). JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL APPLICATIONS 1995;665:183-92. [PMID: 7795790 DOI: 10.1016/0378-4347(94)00523-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
15
Mannaerts GP, Van Veldhoven PP. Metabolic pathways in mammalian peroxisomes. Biochimie 1993;75:147-58. [PMID: 8507676 DOI: 10.1016/0300-9084(93)90072-z] [Citation(s) in RCA: 79] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
16
Mannaerts GP, Van Veldhoven PP. Role of peroxisomes in mammalian metabolism. Cell Biochem Funct 1992;10:141-51. [PMID: 1423894 DOI: 10.1002/cbf.290100303] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
17
Suzuki H, Yamada J, Watanabe T, Suga T. A specific method for determination of peroxisomal beta-oxidation activity in cultured human skin fibroblasts using a specific substrate, C9: a possible application for screening of peroxisomal disorders. Clin Chim Acta 1992;207:19-29. [PMID: 1591864 DOI: 10.1016/0009-8981(92)90147-i] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA